More articles from Drug Discovery and Translational Medicine

You have access
A Novel Sulindac Derivative Protects against Oxidative Damage by a Cyclooxygenase-Independent Mechanism
Shailaja Kesaraju Allani, Ramanjaneyulu Rayala, Oscar Rivera, Howard M. Prentice, Xi Chen, Verónica Ramírez-Alcántara, Joshua Canzoneri, Janet Menzie-Suderam, Xupei Huang, Constantin Georgescu, Jonathan D. Wren, Gary A. Piazza and Herbert Weissbach

Journal of Pharmacology and Experimental Therapeutics August 2022, 382 (2) 79-87; DOI: https://doi.org/10.1124/jpet.122.001086
You have access
Fate Determination Role of Erythropoietin and Romiplostim in the Lineage Commitment of Hematopoietic Progenitors
Xiaoqing Fan, Wojciech Krzyzanski, Raymond S.M. Wong and Xiaoyu Yan

Journal of Pharmacology and Experimental Therapeutics July 2022, 382 (1) 31-43; DOI: https://doi.org/10.1124/jpet.122.001130
You have access
Treatment of γ-Hydroxybutyrate Overdose with the GABA_B Antagonist SGS742
Kristin E. Follman and Marilyn E. Morris

Journal of Pharmacology and Experimental Therapeutics July 2022, 382 (1) 21-30; DOI: https://doi.org/10.1124/jpet.122.001108
You have access
Central Nervous System Delivery of the Catalytic Subunit of DNA-Dependent Protein Kinase Inhibitor Peposertib as Radiosensitizer for Brain Metastases
Surabhi Talele, Wenjuan Zhang, Ju-Hee Oh, Danielle M. Burgenske, Ann C. Mladek, Sonja Dragojevic, Jann N. Sarkaria and William F. Elmquist

Journal of Pharmacology and Experimental Therapeutics June 2022, 381 (3) 217-228; DOI: https://doi.org/10.1124/jpet.121.001069
You have access
Pharmacological Profiling of Antifentanyl Monoclonal Antibodies in Combination with Naloxone in Pre- and Postexposure Models of Fentanyl Toxicity
Carly A. Baehr, Mariah M. Wu, Sujata G. Pandit, Jose Arias-Umana, David AuCoin and Marco Pravetoni

Journal of Pharmacology and Experimental Therapeutics May 2022, 381 (2) 129-136; DOI: https://doi.org/10.1124/jpet.121.001048
Open Access
A Phase I, First-in-Human, Healthy Volunteer Study to Investigate the Safety, Tolerability, and Pharmacokinetics of CVN424, a Novel G Protein-Coupled Receptor 6 Inverse Agonist for Parkinson’s Disease
David H. Margolin, Nicola L. Brice, Antonia M. Davidson, Kim L. Matthews and Mark B. L. Carlton

Journal of Pharmacology and Experimental Therapeutics April 2022, 381 (1) 33-41; DOI: https://doi.org/10.1124/jpet.121.000842
Open Access
Etavopivat, a Pyruvate Kinase Activator in Red Blood Cells, for the Treatment of Sickle Cell Disease
Patricia Schroeder, Keertik Fulzele, Sanjeev Forsyth, Maria D. Ribadeneira, Sylvie Guichard, Erik Wilker, C. Gary Marshall, Adam Drake, Rose Fessler, Diamantis G. Konstantinidis, Katie G. Seu and Theodosia A. Kalfa

Journal of Pharmacology and Experimental Therapeutics March 2022, 380 (3) 210-219; DOI: https://doi.org/10.1124/jpet.121.000743
You have access
The Andrographolide Analogue 3A.1 Synergizes with Taxane Derivatives in Aggressive Metastatic Prostate Cancers by Upregulation of Heat Shock Proteins and Downregulation of MAT2A-Mediated Cell Migration and Invasion
Taraswi Mitra Ghosh, Teeratas Kansom, Suman Mazumder, Joshua Davis, Ahmed S. Alnaim, Shanese L. Jasper, Chu Zhang, Aedan Bird, Praneet Opanasopit, Amit K. Mitra and Robert D. Arnold

Journal of Pharmacology and Experimental Therapeutics March 2022, 380 (3) 180-201; DOI: https://doi.org/10.1124/jpet.121.000898
You have access
A Potent Inhibitor of Aminopeptidase P2 Reduces Reperfusion Injury in Models of Myocardial Infarction and Stroke
Morgan R. Lenz, Shih-Yen Tsai, Anne E. Roessler, Yang Wang, Periannan Sethupathi, W. Keith Jones, Gwendolyn L. Kartje and William H. Simmons

Journal of Pharmacology and Experimental Therapeutics March 2022, 380 (3) 220-229; DOI: https://doi.org/10.1124/jpet.121.000875
Open Access
Pharmacokinetics and Safety Studies in Rodent Models Support Development of EPICERTIN as a Novel Topical Wound-Healing Biologic for Ulcerative Colitis
Daniel Tusé, Micaela Reeves, Joshua Royal, Krystal T. Hamorsky, Hanna Ng, Maria Arolfo, Carol Green, Abhishek Trigunaite, Toufan Parman, Goo Lee and Nobuyuki Matoba

Journal of Pharmacology and Experimental Therapeutics March 2022, 380 (3) 162-170; DOI: https://doi.org/10.1124/jpet.121.000904

Main menu

User menu

Search

More articles from Drug Discovery and Translational Medicine

Pages

Navigate

More Information

ASPET's Other Journals